SK Bioscience Co Ltd (302440) — Net Asset Momentum
SK Bioscience Co Ltd (302440) recorded a net asset momentum of 18.7% as of December 2024, with net assets of ₩2.02 Trillion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See SK Bioscience Co Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
SK Bioscience Co Ltd Net Asset Momentum (2018–2024)
This chart tracks SK Bioscience Co Ltd's year-over-year net asset growth across 7 annual reporting periods from 2018 to 2024. The most recent momentum reading is +18.7%, with net assets of ₩2.02 Trillion KRW as of December 2024. Read SK Bioscience Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for SK Bioscience Co Ltd (2018–2024)
The table below shows the complete annual net asset history for SK Bioscience Co Ltd from 2018 to 2024, covering 7 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see SK Bioscience Co Ltd stock valuation.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩2.02 Trillion | ₩2.84 Trillion | ₩821.14 Billion | ▲ +18.7% |
| 2023 | ₩1.70 Trillion | ₩1.85 Trillion | ₩148.58 Billion | ▼ -2.2% |
| 2022 | ₩1.74 Trillion | ₩2.14 Trillion | ₩400.23 Billion | ▲ +8.8% |
| 2021 | ₩1.60 Trillion | ₩2.11 Trillion | ₩508.81 Billion | ▲ +507.0% |
| 2020 | ₩263.79 Billion | ₩562.23 Billion | ₩298.44 Billion | ▲ +13.3% |
| 2019 | ₩232.73 Billion | ₩403.98 Billion | ₩171.25 Billion | ▲ +10.4% |
| 2018 | ₩210.73 Billion | ₩402.71 Billion | ₩191.98 Billion | — |